Inovio Pharmaceuticals INO
NASDAQ INO
$1.28 -0.04 (-3.03%)
At close: Sep 10, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Asset Utilization Ratio (2011 - 2025)

Inovio Pharmaceuticals' (INO) quarterly Asset Utilization Ratio came in at 0.0 in Q4 2025, down 54.0% year-over-year from 0.0 in Q4 2024, and down 65.68% quarter-over-quarter from 0.0 in Q3 2025.

Analysis

Inovio Pharmaceuticals (INO) Asset Utilization Ratio (2011 - 2025) Analysis & Trends

Inovio Pharmaceuticals has disclosed Asset Utilization Ratio across 15 years of filings, most recently posting 0.0 for Q4 2025.

  • In Q4 2025, Asset Utilization Ratio fell 54.0% year-over-year to 0.0; the TTM figure through Dec 2025 stood at 0.0 (down 54.0% YoY), while the FY2025 annual figure was 0.0, down 54.53% from the prior year.
  • Asset Utilization Ratio came in at 0.0 for Q4 2025 at Inovio Pharmaceuticals, down from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.04 in Q2 2023 to a low of 0.0 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.01, with a median of 0.0 recorded in 2023.
  • Year-over-year, Asset Utilization Ratio surged 871.97% in 2023 and slumped 88.31% in 2024.
  • Over 5 years, Asset Utilization Ratio stood at 0.0 in 2021, then jumped by 705.63% to 0.03 in 2022, then tumbled by 83.51% to 0.0 in 2023, then tumbled by 56.74% to 0.0 in 2024, then sank by 54.0% to 0.0 in 2025.
  • Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.0 in Q4 2025, 0.0 in Q3 2025, and 0.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 0.40
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 0.58
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 0.47
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 0.38
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 0.20
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 0.90
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 0.33
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 0.00
10 Inovio Pharmaceuticals 104.88 Mn 104.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.04
Mar 31, 2023 0.03
Dec 31, 2022 0.03
Sep 30, 2022 0.03
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.01
Jun 30, 2021 0.01
Mar 31, 2021 0.01